CRISPR-based oligo recombineering prioritizes apicomplexan cysteines for drug discovery.
Benns HJ, Storch M, Falco JA, Fisher FR, Tamaki F, Alves E, Wincott CJ, Milne R, Wiedemar N, Craven G, Baragaña B, Wyllie S, Baum J, Baldwin GS, Weerapana E, Tate EW, Child MA.
Benns HJ, et al.
Nat Microbiol. 2022 Nov;7(11):1891-1905. doi: 10.1038/s41564-022-01249-y. Epub 2022 Oct 20.
Nat Microbiol. 2022.
PMID: 36266336
Free PMC article.